218 related articles for article (PubMed ID: 10981103)
1. Calcium-channel blockers and the progression of renal disease.
Griffin KA; Bidani AK
Curr Hypertens Rep; 1999 Oct; 1(5):436-45. PubMed ID: 10981103
[TBL] [Abstract][Full Text] [Related]
2. Antihypertensive treatment of patients with proteinuric renal diseases: risks or benefits of calcium channel blockers?
Kloke HJ; Branten AJ; Huysmans FT; Wetzels JF
Kidney Int; 1998 Jun; 53(6):1559-73. PubMed ID: 9607186
[TBL] [Abstract][Full Text] [Related]
3. Renal protection in hypertensive patients: selection of antihypertensive therapy.
Wenzel RR
Drugs; 2005; 65 Suppl 2():29-39. PubMed ID: 16398060
[TBL] [Abstract][Full Text] [Related]
4. Renal protection and antihypertensive drugs: current status.
Salvetti A; Mattei P; Sudano I
Drugs; 1999 May; 57(5):665-93. PubMed ID: 10353294
[TBL] [Abstract][Full Text] [Related]
5. Ca2+ channel subtypes and pharmacology in the kidney.
Hayashi K; Wakino S; Sugano N; Ozawa Y; Homma K; Saruta T
Circ Res; 2007 Feb; 100(3):342-53. PubMed ID: 17307972
[TBL] [Abstract][Full Text] [Related]
6. Investigational calcium channel blockers for the treatment of hypertension.
Tamargo J; Ruilope LM
Expert Opin Investig Drugs; 2016 Nov; 25(11):1295-1309. PubMed ID: 27696904
[TBL] [Abstract][Full Text] [Related]
7. HYT-hypertension in Turkey: a cross-sectional survey on blood pressure control with calcium channel blockers alone or combined with other antihypertensive drugs.
Seravalle G; Koylan N; Nalbantgil I; Caglar N; Quarti-Trevano F; Makel W; Grassi G; Fici F
High Blood Press Cardiovasc Prev; 2015 Jun; 22(2):165-72. PubMed ID: 25900022
[TBL] [Abstract][Full Text] [Related]
8. The case for combining angiotensin-converting enzyme inhibitors and calcium-channel blockers.
Taylor AA; Sunthornyothin S
Curr Hypertens Rep; 1999 Oct; 1(5):446-53. PubMed ID: 10981104
[TBL] [Abstract][Full Text] [Related]
9. Calcium channel blockers in cardiovascular pharmacotherapy.
Godfraind T
J Cardiovasc Pharmacol Ther; 2014 Nov; 19(6):501-15. PubMed ID: 24872348
[TBL] [Abstract][Full Text] [Related]
10. T-type Ca channel blockade as a determinant of kidney protection.
Hayashi K; Homma K; Wakino S; Tokuyama H; Sugano N; Saruta T; Itoh H
Keio J Med; 2010; 59(3):84-95. PubMed ID: 20881449
[TBL] [Abstract][Full Text] [Related]
11. Use of calcium channel blockers in cardiovascular risk reduction: issues in Latin America.
Alcocer L; Bendersky M; Acosta J; Urina-Triana M
Am J Cardiovasc Drugs; 2010; 10(3):143-54. PubMed ID: 20524716
[TBL] [Abstract][Full Text] [Related]
12. Comparison of L-type and mixed L- and T-type calcium channel blockers on kidney injury caused by deoxycorticosterone-salt hypertension in rats.
Baylis C; Qiu C; Engels K
Am J Kidney Dis; 2001 Dec; 38(6):1292-7. PubMed ID: 11728963
[TBL] [Abstract][Full Text] [Related]
13. Class differences in the effects of calcium channel blockers in the rat remnant kidney model.
Griffin KA; Picken MM; Bakris GL; Bidani AK
Kidney Int; 1999 May; 55(5):1849-60. PubMed ID: 10231447
[TBL] [Abstract][Full Text] [Related]
14. [Are all antihypertensive drugs renoprotective?].
Wolf S; Risler T
Herz; 2004 May; 29(3):248-54. PubMed ID: 15167950
[TBL] [Abstract][Full Text] [Related]
15. Calcium channel blockers in the prevention of end stage renal disease: a review.
Derwa A; Peeters P; Vanholder R
Acta Clin Belg; 2004; 59(1):44-56. PubMed ID: 15065696
[TBL] [Abstract][Full Text] [Related]
16. Potential risks of calcium channel blockers in chronic kidney disease.
Griffin KA; Bidani AK
Curr Cardiol Rep; 2008 Nov; 10(6):448-55. PubMed ID: 18950553
[TBL] [Abstract][Full Text] [Related]
17. Calcium channels blockers and progression of kidney disease.
Ziakka S; Kaperonis N; Ferentinou E; Karakasis F; Ntatsis G; Kourvelou C; Papagalanis N
Ren Fail; 2007; 29(8):1003-12. PubMed ID: 18067048
[TBL] [Abstract][Full Text] [Related]
18. Calcium channel blockers in the spectrum of antihypertensive agents.
Liebson PR
Expert Opin Pharmacother; 2006 Dec; 7(17):2385-401. PubMed ID: 17109613
[TBL] [Abstract][Full Text] [Related]
19. Calcium channel blockers and hypertension.
Tocci G; Battistoni A; Passerini J; Musumeci MB; Francia P; Ferrucci A; Volpe M
J Cardiovasc Pharmacol Ther; 2015 Mar; 20(2):121-30. PubMed ID: 25398848
[TBL] [Abstract][Full Text] [Related]
20. Cardiovascular and renal protection in type 2 diabetes mellitus: the role of calcium channel blockers.
Nosadini R; Tonolo G
J Am Soc Nephrol; 2002 Nov; 13 Suppl 3():S216-23. PubMed ID: 12466317
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
